MapLight Therapeutics MPLT
NASDAQ MPLT
$8.19 -0.05 (-0.61%)
As of: Oct 21, 2026 · 3:46 PM EDT

MapLight Therapeutics (MPLT) Total Current Liabilities (2024 - 2026)

Updated

MapLight Therapeutics' Total Current Liabilities was $19.29 million in Q2 2026.

Analysis

MapLight Therapeutics (MPLT) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at MapLight Therapeutics came in at $16.23 million, up 1.9% from FY2024.

  • In earlier years, Total Current Liabilities was $15.92 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,138.83 Bn 1,107.41 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 618.88 Bn 537.41 Bn 17.26 Bn 54.90 Bn
3 AbbVie 502.93 Bn 476.04 Bn 12.70 Bn 41.64 Bn
4 Merck 369.61 Bn 323.99 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.70 Bn 262.69 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.59 Bn 192.99 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.60 Bn 165.79 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.23 Bn 116.88 Bn 10.94 Bn 32.65 Bn
10 MapLight Therapeutics 372.08 Mn 372.08 Mn - 19.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.29 Mn
Dec 31, 2025 16.23 Mn
Sep 30, 2025 18.56 Mn
Dec 31, 2024 15.92 Mn
API Access

MapLight Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=MPLT&period=max&api_key=YOUR_API_KEY